Drug intelligence / Profile preview

morphine + oxycodone + acetaminophen

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination drug containing three active ingredients: morphine, oxycodone, and acetaminophen. Morphine and oxycodone are both opioid analgesics that act primarily as agonists at the mu-opioid receptor in the central nervous system, leading to inhibition of pain signaling and providing potent analgesia. Acetaminophen is a non-opioid analgesic and antipyretic that works by inhibiting prostaglandin synthesis in the central nervous system, though its precise mechanism for pain relief remains not fully understood. This combination would be expected to provide strong pain relief for severe acute or chronic pain unresponsive to other treatments. However, there is no evidence from available sources that such a triple combination (morphine + oxycodone + acetaminophen) exists as an approved or marketed pharmaceutical product; combinations of two of these agents (e.g., oxycodone + acetaminophen) are widely used[1][3][6]. The use of multiple opioids together with acetaminophen would raise significant safety concerns regarding additive opioid toxicity (respiratory depression, sedation), risk of dependence/abuse, and potential for liver toxicity from high doses of acetaminophen.

Other names
morphine + oxycodone-University of Puerto Rico-postoperative painopioid-based regimenstandard opioid therapy
02

Targets

KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)COX

Beyond the preview

Go deeper on morphine + oxycodone + acetaminophen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + oxycodone + acetaminophen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call